
    
      Pragmatic, multicenter, 2x2 factorial randomized study. Severe patients admitted to the ICU
      at moderate to high risk for death or acute kidney injury will be randomly allocated to
      receive a balanced crystalloid solution (Plasma-LyteÂ®) or 0.9% saline and to receive
      crystalloids by rapid bolus infusion (999 mL/h) or slow infusion (333 mL/h) whenever plasma
      expansion is needed.
    
  